San Francisco, CA, United States of America

Wai Ki Vicky Chan



Average Co-Inventor Count = 16.9

ph-index = 3

Forward Citations = 18(Granted Patents)


Company Filing History:


Years Active: 2012-2013

Loading Chart...
Loading Chart...
4 patents (USPTO):Explore Patents

Title: Innovations of Wai Ki Vicky Chan

Introduction

Wai Ki Vicky Chan is a notable inventor based in San Francisco, CA. She has made significant contributions to the field of pharmaceuticals, particularly in the development of novel compounds that target specific biological pathways. With a total of 4 patents to her name, her work has the potential to impact various therapeutic areas.

Latest Patents

Wai Ki Vicky Chan's latest patents include innovative compounds such as 4-aryl-2-amino-pyrimidines or 4-aryl-2-aminoalkyl-pyrimidines, which serve as JAK-2 modulators. This invention relates to certain pyrimidine derivative inhibitors of JAK-2, which are defined by specific formulas and include pharmaceutically acceptable salts and compositions. Another significant patent involves pyrimidinones as casein kinase II (CK2) modulators. This compound also has a defined formula and includes pharmaceutical compositions and methods of use, targeting the CK2 pathways.

Career Highlights

Wai Ki Vicky Chan is currently employed at Exelixis, Inc., where she continues to advance her research and development efforts. Her work at Exelixis has positioned her as a key player in the pharmaceutical industry, contributing to the discovery of new therapeutic agents.

Collaborations

Throughout her career, Wai Ki Vicky Chan has collaborated with esteemed colleagues, including Hongwang Du and Patrick C Kearney. These collaborations have fostered a productive research environment, leading to innovative solutions in drug development.

Conclusion

Wai Ki Vicky Chan's contributions to the field of pharmaceuticals through her patents and collaborations highlight her role as an influential inventor. Her work continues to pave the way for advancements in therapeutic agents that may benefit many.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…